Proliferative arrest |
Low expression of Ki-67 or bromodeoxyuridine BrdU |
Persistent activation of the DNA damage response |
Activation of tumour suppressors, such as p53, p16INK4A, cyclins, and cyclin-dependent kinases |
Heterochromatic foci (DNA becomes denser than normal) |
Senescence-associated heterochromatic foci on DNA staining with DAPI |
Cells become flattened and enlarged |
Light microscopy changes |
Altered metabolism including increased β-galactosidase activity, which is part of carbohydrate metabolism |
Measurement of β-galactosidase levels |
Senescence-associated secretory phenotype |
Interleukins-1, -6, and -8, matrix metalloproteinases, plasminogen activator inhibitor-1 |